We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+14.13%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$24.4B
AUM Growth
+$627M
Cap. Flow
-$540M
Cap. Flow %
-2.21%
Top 10 Hldgs %
48.29%
Holding
168
New
24
Increased
37
Reduced
33
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 33.14%
2 Technology 11.51%
3 Financials 9.33%
4 Communication Services 4.99%
5 Industrials 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYG icon
1
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$3.17B 12.96%
39,000,000
+21,000,000
+117% +$1.69B
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$2.27B 9.27%
+3,400,000
New +$2.18B
MSFT icon
3
Microsoft
MSFT
$2.84T
$991M 4.06%
1,913,135
+165,300
+9% +$84.3M
RSP icon
4
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$967M 3.96%
5,100,000
+2,800,000
+122% +$522M
AON icon
5
Aon
AON
$77.3B
$812M 3.33%
2,278,017
+291,600
+15% +$105M
EXEL icon
6
Exelixis
EXEL
$13.9B
$805M 3.3%
19,501,500
+3,466,000
+22% +$139M
AMZN icon
7
Amazon
AMZN
$2.5T
$770M 3.15%
3,505,700
+471,100
+16% +$107M
NTRA icon
8
Natera
NTRA
$37.5B
$685M 2.8%
4,253,452
-568,357
-12% -$89.9M
RVMD icon
9
Revolution Medicines
RVMD
$40.2B
$683M 2.8%
14,625,692
+300,000
+2% +$11.7M
UNH icon
10
UnitedHealth
UNH
$382B
$651M 2.67%
1,886,500
+269,200
+17% +$81.4M
TMO icon
11
Thermo Fisher Scientific
TMO
$211B
$610M 2.5%
1,258,241
-125,000
-9% -$58.2M
HIMS icon
12
Hims & Hers Health
HIMS
$6.5B
$610M 2.5%
10,746,852
+2,533,271
+31% +$130M
DIS icon
13
Walt Disney
DIS
$165B
$595M 2.44%
5,198,968
+324,700
+7% +$38.2M
CRM icon
14
Salesforce
CRM
$134B
$584M 2.39%
2,462,310
+353,200
+17% +$89.1M
ADSK icon
15
Autodesk
ADSK
$44.3B
$528M 2.16%
1,662,852
-81,800
-5% -$24.9M
BSX icon
16
Boston Scientific
BSX
$65.8B
$463M 1.9%
4,746,557
+765,500
+19% +$79.3M
IBIT icon
17
iShares Bitcoin Trust
IBIT
$47.2B
$455M 1.86%
6,992,700
-27,350
-0.4% -$1.78M
WAB icon
18
Wabtec
WAB
$51.1B
$442M 1.81%
2,205,098
+896,900
+69% +$177M
BBIO icon
19
BridgeBio Pharma
BBIO
$16.5B
$425M 1.74%
8,192,000
+292,000
+4% +$14.2M
PTGX icon
20
Protagonist Therapeutics
PTGX
$8.75B
$412M 1.68%
6,196,006
+24,000
+0.4% +$1.36M
TRU icon
21
TransUnion
TRU
$14.8B
$396M 1.62%
4,732,075
-672,500
-12% -$61.1M
ARMK icon
22
Aramark
ARMK
$15B
$345M 1.41%
8,996,202
-3,903,499
-30% -$158M
INTU icon
23
Intuit
INTU
$81.1B
$333M 1.36%
488,088
-48,570
-9% -$35M
K
24
DELISTED
Kellanova
K
$323M 1.32%
3,943,853
+2,180,721
+124% +$173M
NDAQ icon
25
Nasdaq
NDAQ
$51.5B
$320M 1.31%
3,623,043
-460,700
-11% -$42.7M

Similar funds

Farallon Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Farallon Capital Management held 168 positions worth $24.4B, up 2.6% from $23.8B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Farallon Capital Management's Q3 2025 filing shows 24 new, 37 increased, 33 reduced and 24 closed positions. Its largest new stake was iShares Ethereum Trust ETF: 7,450,730 shares worth $235M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.53B.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q3 2025 buy was iShares Ethereum Trust ETF: 7,450,730 shares worth $235M.
  • Farallon Capital Management added most to Wabtec in Q3 2025, an estimated $177M increase.
  • Farallon Capital Management's biggest Q3 2025 reduction was IQVIA, cutting an estimated $530M.
  • Farallon Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q3 2025, selling an estimated $3.53B.
  • Farallon Capital Management's ten largest holdings make up 48% of its $24.4B portfolio in Q3 2025.
  • Farallon Capital Management opened 24 new positions and closed 24 in Q3 2025.
  • Farallon Capital Management's portfolio value rose 2.6% quarter-over-quarter to $24.4B.

Based on Farallon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.